Treatment of Essential Hypertension

Size: px
Start display at page:

Download "Treatment of Essential Hypertension"

Transcription

1 2016 edition by Mark A. Simmons, PhD Department of Pharmaceutical Sciences School of Pharmacy University of Maryland Eastern Shore Originally developed by Hugh J. Burford, PhD, FCP Department of Pharmacology Schools of Medicine and Pharmacy University of North Carolina Chapel Hill and Patricia B. Williams, PhD, FCP Department of Pharmacology Eastern Virginia Medical School Norfolk Note to Students The fundamental purposes of all activities in the health-care professions are to help other people. Like all behavior, helping behavior becomes more effective and natural with practice. This exercise enables you to practice by helping your fellow students to learn basic science. Your skill at helping your fellow students should relate to your ability to help your patients in the future. This is a Patient-Oriented Problem-Solving (POPS) exercise designed for four students. Before beginning this session, you should have (a) studied the objectives designed to prepare you for it, (b) taken the pretest, and (c) reviewed the topics listed at the end of the pretest. Now, each of you should take one of the four color-coded parts and follow the directions in it. If your group has only three students, one of you should take two parts. If your group has more than four students, two should take turns with a part. Please begin by discussing the answers to the pretest.

2 Correct s to Pretest Questions In the discussion to follow, you are given the correct answers to some of the 10 pretest questions, along with explanations. Other students in your group have been given the answers to other questions. This allocation of answers and explanations is designed to encourage all members of your group to actively exchange ideas and concepts. First, study the answers in your part and then EXPLAIN them to your group. Don't simply read the answers to your classmates, and don't let your classmates read their answers to you. In explaining something to another person, most people gain and often transmit a better understanding of the subject. The pretest discussion and patient-oriented problem-solving parts of this activity are "open book"; be sure to refer to textbooks, notes, and other written resources whenever questions arise. To help you review any questions that you may have missed, you probably will want to make notes on your pretest answer sheets. However, avoid "collecting pages" for later study and understanding." Learn the concepts now so that later you will only need to review them. 1. You should have selected D because nitroprusside has a rapid predictable antihypertensive effect and decreases venous return and cardiac work. B, promotion of fluid and sodium retention, is an undesirable characteristic. This side effect is not produced by nitroprusside. 5. B is correct. Losartan is an angiotensin II receptor blocker (ARB). ARBs may induce a more complete inhibition of the renin-angiotensin system than the ACE inhibitors, such as captopril. Hydrochlorothiazide is a diuretic, which inhibits sodium reabsorption in the distal tubule. Clonidine is an α 2 -adrenergic-receptor antagonist. Nifedipine is a calcium channel blocker. When your group has finished discussing all of the pretest questions, read Instructions for the Clinical Problem" on the next page. 2

3 Instructions for the Clinical Problem In the remainder of this exercise, you are to use your knowledge of the pharmacology of antihypertensive drugs to decide appropriate therapy for Harry Hypertensive. Each of the four members of your group has information about one episode in Mr. Hypertensive's medical history and part of the drug data necessary to find the best therapy for him. Thus, you must share information and work together to treat his hypertension. When the episode for which you are responsible comes up, read it to the group and lead a discussion of the questions included with the episode. Pose each question to a different member of the group. Use the Discussion Notes provided as a guide for the discussion. DO NOT SIMPLY READ THE NOTES to the group. Learning is facilitated by active processes such as thinking about the questions and their possible solutions. Do not stop discussing a question until every member of the group is completely satisfied with the answer. During the discussion, members of the group may consult textbooks, notes, and any other reference material. This is a group effort. Work together and teach one another. As the group member whose part contains Episode 1, you should begin the discussion. 3

4 Episode 1 Harry Hypertensive, is a 40-year-old white male stockbroker with type A behavior. Harry is slightly overweight (BMI = 25.1) and is not very athletic. He has recently visited his physician for a physical examination. It had been 2 to 3 years since his last physical. His blood pressure (BP) was 170/110 mm Hg and his heart rate (HR) was 80 beats per minute (bpm). All other physical findings were within normal limits; there were normal fundi, no cardiomegaly, and no evidence of abdominal bruits. Harry has a strong family history of hypertension. Serum electrolytes, creatinine, cholesterol, and urinalysis are within normal limits. Harry has no physical complaints. Ask one of your classmates if drug therapy should be considered for Harry. Should therapy be started now? Why or why not? (: Don't begin therapy now. You would first confirm that his BP was elevated at a second visit. With this degree of hypertension, the patient should be reevaluated and within 1 month, but it can be done in one week or even few days. If there is any evidence of end organ damage, if initial BP is greater than 180/110, or if there are any symptoms of hypertensive emergency present, diagnosis of hypertension can be made on the first visit.) Now, ask a different classmate if drug therapy should be initiated. (: For Stage 1 hypertension [diastolic 90 to 99 mm Hg] drug therapy is needed. However, lifestyle changes are important and should be taught to the patient to enhance drug efficacy and reduce the dose of antihypertensives used.) At follow-up, Harry's average supine BP is 162/112 mm Hg with a HR of 76 bpm, and his standing BP is 155/112 mm Hg with a HR of 82 bpm. You decide that drug therapy is required. Now you must recall the physiological regulation of BP and how the different categories of antihypertensive drugs work. To accomplish this, ask your colleagues to review Handout 1. Allow 5 minutes for each member of the group, including yourself, to review the information. 4

5 HANDOUT 1 for use with Episode 1 ANTIHYPERTENSIVE DRUG CATEGORIES AND AGENTS Antihypertensive Physiologic Side Category Dose (mg/day) Effect Effects 1. Thiazide and Related Diuretics Hydrochlorothiazide TPR, hypovolemia, Hypokalemia, hyperuricemia, (HCTZ) secondary sodium hyponatremia, insulin sensitivity, hyperglycemia, hyperlipoproteinemia, digitalis intoxication Chlorthalidone Same as HCTZ Same as HCTZ Indapamide Same as HCTZ Same as HCTZ Metolazone Same as HCTZ Same as HCTZ 2. Calcium-Channel Blockers Nifedipine Direct vasodilation Constipation, tachycardia, headaches, edema Nicardipine Same as nifedipine Same as nifedipine Amlodipine 5-10 Same as nifedipine Same as nifedipine Diltiazem Same as nifedipine Bradycardia, edema, but less vasodilation heart block Verapamil Same as nifedipine Constipation, heart block but less vasodilation 3. ACE Inhibitors Captopril Total peripheral Cough, hyperkalemia, resistance, with BP, angioedema, rash, proteinuria, and renal flow teratogenic Enalapril 5-40 Same as captopril Same as captopril Lisinopril Same as captopril Same as captopril

6 Antihypertensive Physiologic Side Category Dose (mg/day) Effect Effects 4. ARBs Losartan Total peripheral Same as ACE inhibitors resistance, with BP, with less cough and renal flow Candesartan Same as losartan Same as losartan Eprosartan Same as losartan Same as losartan Irbesartan Same as losartan Same as losartan Olmesartan Same as losartan Same as losartan Valsartan Same as losartan Same as losartan 5. Other diuretics a. Loop diuretics Furosemide hypovolemia Same as HCTZ secondary to Na+ b. Aldosterone antagonist diuretics Spironolactone Mineralocorticoid Gynecomastia, libido, antagonist menstrual disorders c. Potassium-sparing diuretics Triamterene Na/K exchange Nausea, hyperkalemia at distal tubule renal function Amiloride 5-20 Same as triamterene Nausea, hyperkalemia 6. Sympatholytic Drugs a. β-blockers Propranolol cardiac output, Bronchoconstriction, renin release, heart failure, fatigue, reflex inhibition of sympathetic peripheral vasoconstriction, neurotransmission bradyarrhythmias, prolonged insulin reactions, libido

7 Antihypertensive Physiologic Side Category Dose (mg/day) Effect Effects a. β-blockers (cont.) Nadolol Same as propranolol Same as propranolol but more but longer effect accumulation, renal failure Timolol Same as propranolol Same as propranolol Pindolol 5-60 Same as propranolol Same as propranolol but less plus intrinsic bradycardia and less sympathomimetic activity peripheral vasoconstriction Labetalol Same as propranolol Same as propranolol plus α 1 -receptor blocking activity Metoprolol Same as propranolol, Same as propranolol, with less ß 1 -receptor selective bronchoconstriction, effect on insulin-induced hypoglycemia and peripheral vasoconstriction Betaxolol Same as metoprolol Same as metoprolol Atenolol Same as metoprolol Same as metoprolol but longer effect but accumulation with renal failure Acebutolol Same as metoprolol Same as metoprolol and pindolol and pindolol Carvedilol Same as labetalol Same as metoprolol plus α 1 -receptor blocking Nebivolol 5-40 Same as metoprolol Same as metoprolol b. Central α-agonists Methyldopa Decreased central Somnolence, orthostatic sympathetic outflow, hypotension, fever, hepatitis renin hemolytic anemia, libido Clonidine Same as methyldopa Sedation, dry mouth, withdrawal hypertension, libido

8 Antihypertensive Physiologic Side Category Dose (mg/day) Effect Effects b. Central α-agonists (cont.) Guanfacine 1-3 Same as methyldopa Same as clonidine c. Depletor of Norepinephrine Stores Reserpine Central/peripheral Depression, peptic ulcer, catecholamine depletion libido, nasal congestion d. α 1 -Blockers Prazosin 1-20 Peripheral α 1 - Postural hypotension, blockade leading to syncope, favorable plasma TPR, venous lipid shifts capacitance Doxazosin 1-16 Same as prazosin Same as prazosin Terazosin 1-40 Same as prazosin Same as prazosin 7. Vasodilators Hydralazine Direct artery Tachycardia, myocardial vasodilation ischemia, systemic lupus erythematosus Minoxidil Same as hydralazine Tachycardia, myocardial ischemia, edema, hypertrichosis, pericardial effusion Sodium nitroprusside IV Arterial and venous Hypotension, dilation reflex tachycardia cyanide buildup Additional agents in the above classes are available commercially. When the group members have reviewed the regulation of blood pressure and Antihypertensive Drug Categories, make sure that everyone understands the mechanism of BP lowering for each category of drugs before you proceed. Also make sure everyone understands the physiological regulation of BP. Use your slides or any other material and make notes as needed.

9 Therapy Sheets A through D. Ask each person to study their own Therapy Sheet. You start with Therapy Sheet A. Then have the group members take turns asking the rest of the group about the drugs on their own Therapy Sheet. 1. What is the mechanism of action of the drug? 2. What are the advantages, disadvantages, and/or complications associated with the use of the drug? 5

10 Therapy Sheet A: Hydrochlorothiazide (diuretic) - Student 1 Study this page and then ask your colleagues the following questions: 1. What is the mechanism of action of diuretics, in general, and hydrochlorothiazide, in particular? Diuretics block sodium, potassium, and chloride cotransport in the ascending limb of the loop of Henle (e.g., furosemide) or sodium chloride reabsorption in the distal tubule (e.g., hydrochlorothiazide). The net effect is sustained salt and water loss, contraction of extracellular fluid volume (ECFV) with consequent reduction in cardiac output. Decreased cardiac output contributes to reduced glomerular filtration rate and renal blood flow during diuretic therapy. The thiazides have an additional vasodilator effect through activation of adenosine triphosphate (ATP)-sensitive potassium channels in vascular smooth muscle. For diuretics the reduced ECFV is most significant in chronic therapy. This is shown by the ability of salt to reverse the antihypertensive effect of diuretics and by the increased plasma renin activity and aldosterone excretion from the decreased ECFV during diuretic therapy. 2. What are the advantages, disadvantages, and complications associated with the use of diuretics and hydrochlorothiazide? Advantages: are synergistic antihypertensive effects with most other drugs used. Also, diuretics are able to lower body sodium chloride load and thus enhance the antihypertensive effect. Disadvantages and complications: center on the metabolic actions of hydrochlorothiazide. This diuretic class increases blood sugar, calcium, uric acid, and cholesterol and reduces serum potassium. In addition, increases in dietary sodium will antagonize the antihypertensive effect of all diuretics.

11 Therapy Sheet B: Losartan (angiotensin II receptor blocker) - Student 2 When prompted during Episode 1, study this page and then ask your colleagues the following questions: 1. What is the mechanism of action of losartan? Angiotensin II receptor blockers (ARBs) are antagonists of angiotensin II at the AT1 receptor. ARBs reduce blood pressure by blocking the effects of angiotensin II, a vasoconstrictor. Angiotensin II receptor blockade produces vasodilatation with reduction of total peripheral resistance and a decrease in blood pressure. ARBs also increase urinary sodium and water excretion and reduce plasma volume. 2. What are the advantages, disadvantages, and complications associated with the use of ARBs? Advantages: ARBs provide a more direct inhibition of angiotensin II action, by acting directly at the angiotensin II (type AT1) receptor. In addition to ACE, there are other enzymes that can produce angiotensin II that are not blocked by ACE inhibitors. ARBs appear to be just as effective as ACE inhibitors in treating hypertension. Cough is less frequent with ARBs than with ACE inhibitors. Angioedema is a rare severe reaction, seen less frequently than with ACE inhibitors. Disadvantages and complications: Like ACE inhibitors, ARBs increase serum potassium due to blockade of angiotensin-stimulated aldosterone. ARBs also can cause complications in special patients and with high doses. Since these drugs decrease glomerular filtration, they must be used with caution in patients with renal artery stenosis. ARBs, like ACE inhibitors, can cause fetal abnormalities and should not be used in pregnancy.

12 Therapy Sheet C: Amlodipine (calcium-channel blockers) - Student 3 When prompted during Episode 1, study this page and then ask your colleagues the following questions: 1. What is the mechanism of action of nifedipine? Block L-type calcium channels in vascular smooth muscle cells. Depolarization and contraction of vascular smooth muscle depends mainly on the influx of Ca 2+ ; thus, Ca 2+ channel blockade leads to vasodilation. Nifedipine is more potent as an arteriolar vasodilator and has less effect on S-A and A-V node conduction than verapamil. The result is usually a slight increase in heart rate that offsets the negative inotropic effect of calcium antagonism. 2. What are the advantages, disadvantages, and complications associated with the use of calcium-channel blockers? Advantages: Nifedipine may be used to treat all degrees of hypertension but is used most for moderate to severe hypertension. It may be combined with β-blockers to reduce side effects and to enhance antihypertensive and antianginal effects. Also, it may be given sublingually for rapid onset of action. Disadvantages and complications: Disadvantages include tachycardia, headaches, edema, and constipation. Interactions can occur with other medications (e.g., hypotension with quinidine, increased levels of digoxin, and increased levels of nifedipine with cimetidine).

13 Therapy Sheet D: Lisinopril (ACE inhibitors) - Student 4 When prompted during Episode 1, study this page and then ask your colleagues the following questions: 1. What is the mechanism of action of lisinopril? ACE inhibitors block the conversion of angiotensin I to the vasoactive angiotensin II. ACE inhibitors reduce blood pressure by several mechanisms, but the most important is believed to be reduction of angiotensin II levels. The result is arteriolar dilatation with reduction of total peripheral resistance and increased urinary sodium and water excretion. 2. What are the advantages, disadvantages, and complications associated with the use of ACE inhibitors? Advantages: Lisinopril is effective in both mild and severe forms of renin-dependent hypertension. Absence of side effects in most patients makes lisinopril a choice for first-drug therapy of hypertension. It may be combined with other antihypertensive drugs to produce additive effects. The newer ACE inhibitors, enalapril, lisinopril, and ramipril, have longer durations of action and fewer adverse effects. Disadvantages and complications: Lisinopril is generally well tolerated in adequate doses, but causes a chronic cough in many patients, especially women. It does raise serum potassium due to blockade of angiotensin-stimulated aldosterone. Other common side effects include macropapular rash, angioneurotic edema, and a decreased sense of taste. Elderly white patients respond better to monotherapy than black patients. Finally, captopril's antihypertensive effect is antagonized by indomethacin and aspirin. ACE inhibitors should not be used in pregnancy. Since these drugs decrease glomerular filtration, they must be used with caution in patients with bilateral renal artery stenosis, but are the drug of choice for therapy of renovascular hypertension due to unilateral renal artery stenosis. In high doses (e.g., 150 mg/day, captopril) leukopenia and rash are often seen.

14 After you have reviewed the pharmacology of the antihypertensive drugs, use the following questions and the Discussion Notes to guide the discussion. Each member of the group should take the lead in answering at least one of the questions. 1.1 Do you choose to start Mr. Hypertensive on single-drug or multiple-drug therapy? Give the reasons for your choice. 1.2 What class of antihypertensive drug would be most appropriate for the initial treatment of Mr. Hypertensive? Give reasons for this choice. Give three advantages and three disadvantages. Make sure the group comes to a consensus and picks a single drug and class. 1.3 What advice should be given to Mr. Hypertensive to emphasize compliance and adjunctive treatments? 1.4 How would the following factors alter the choice? The patient is black, elderly, diabetic, asthmatic, or has congestive heart failure. 1.5 What is the therapeutic goal? 6

15 Discussion Notes for Questions in Episode The JNC 8 evidence-based guidelines (JAMA. 2014;311(5): doi: /jama ) call for initiation of therapy with a thiazide-type diuretic, an angiotensin-converting enzyme inhibitor (ACEI), an angiotensin II receptor blocker (ARB) or a calcium-channel blocker (CCB), alone or in combination. Some clinicians prefer to start with a low dose of one drug and adjust the amount toward the upper limit of the dose-therapeutic response curve, while carefully observing the patient for unwanted side effects, before adding a second drug. Other practitioners consider the addition of a second medication with a different mechanism of action before complete upward titration of the first medication. Still others will initiate treatment with a combination of drugs from two of the above-mentioned classes. In patients without coexisting disease, any of these choices will result in comparable effects on overall mortality. 1.2 Thiazides, angiotensin II receptor blockers, angiotensin-converting enzyme inhibitors, or calcium-channel blockers would be appropriate choices. Harry is asymptomatic, feels well, and has no known cardiac irregularities. The degree of his hypertension is Stage 1. He has not been previously treated and therefore his responsiveness to drug therapy should be good. Because the thiazide-type diuretics are (1) effective in most patients with mild to moderate hypertension and (2) have minimal side effects, they may be the best choice for initial therapy in a previously untreated patient; in addition, (3) diuretics usually increase the effects of other antihypertensive drugs. Therefore, if a second drug must be added to the regimen, lower doses of the second drug may be adequate to achieve your therapeutic goal. This effect of the diuretic drugs is probably related to the prevention of salt and water retention that frequently accompanies the use of other antihypertensive drugs. Some clinicians favor the use of calcium-channel blockers, ARBs, or ACEIs as initial therapy in hypertension. ARBs or ACEIs may be logical first-choice drugs in patients who have heart disease or chronic kidney disease. ACEIs do synergize with diuretics but raise serum potassium due to blockade of angiotensin-stimulated aldosterone. Finally, calcium-channel blockers also may be used as first-choice drugs for mild essential hypertension; especially verapamil in the patient who may have angina pectoris or other disease indication for verapamil. However, amlodipine is thought to be a more effective drug for moderate to severe hypertension. 7

16 1.3 Advise Harry to a. take his medicine regularly (patient compliance) although he feels well. b. reduce his sodium intake. c. cut down on cigarette smoking and alcohol intake. d. start a moderate exercise program (e.g., walk one mile a day) e. lose 10 pounds and maintain his weight at that level. Discuss the consequences of hypertension with Harry, emphasizing the need to control his blood pressure for good health. Also, discuss the ease of controlling blood pressure with simple drugs added to the nonpharmacologic factors above. 1.4 Patient factors such as race, age, and the presence of complicating diseases such as asthma, diabetes, dyslipidemias, or heart failure always complicate therapy. African Americans have a general insensitivity to ARBs, ACEIs, and β-blockers. Elderly patients may respond better to thiazides and CCBs than to ACEIs and ARBs. β-blockers may worsen the symptoms of asthmatic patients and prolong hypoglycemia of diabetic patients by retarding the blood glucose rebound following insulin. β-blockers and thiazides can also affect blood lipids, while ACE inhibitors, ARBs and CCBs are lipid neutral. Blood pressure and blood volume control with either an ACEI or ARB and a thiazide diuretic is typical in heart failure patients with reduced left ventricular function. 1.5 The therapeutic goal is to prevent end-organ damage to the kidneys, heart, vasculature, and central nervous system (CNS). In the young patient with no other disease, the goal is obviously maintenance of normal blood pressure at an affordable cost. In elderly patients with complicating disease, the goal is to keep them as comfortable as possible while normalizing their blood pressure as much as possible. Most experts agree that regular administration of antihypertensive agents may be necessary for the control of blood pressure. However, adjuncts to drug therapy may obviate the need for initial therapy or, in Harry's case, to add additional drugs to his regimen. Most clinicians agree that exercise, reduced salt intake, and maintenance of weight in the normal range (BMI = ) are beneficial adjuncts to therapy. High alcohol intake (4 to 6 drinks/day) results in a significant increase in the incidence of hypertension. Low to moderate alcohol intake increases levels of high-density lipoprotein (HDL) cholesterol and may decrease the incidence of atherosclerosis. It is clear that smoking causes oral and lung cancers and is a major cause of cardiovascular mortality and obstructive lung disease. All these conditions complicate the therapy of hypertension. After the initial drug for Harry has been selected, the group member whose part contains Episode 2 should now take over as discussion leader. 8

17 HANDOUT 2 for use in Episode 2 GUIDELINES FOR TREATMENT OF ESSENTIAL HYPERTENSION Step 0. Nonpharmacologic Approaches (Lifestyle Interventions): sodium and alcohol restriction, weight control, and control of other cardiovascular risk factors. Step 1. In nonblack patients, begin with a low dose of either 1) a thiazide diuretic, 2) calcium channel blocker, or 3) angiotensin inhibitor (angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB)). These 3 classes of drugs can be administered alone or in combination. Avoid combined use of ACE inhibitors and ARBs.In black patients, initiate therapy with either 1) a thiazide diuretic or 2) a calcium channel blocker, alone or in combination. Step 2. Select a drug treatment titration strategy. Decide to either A) maximize a first medication before adding a second, B) add a second medication before reaching the maximum tolerable dose of the first, or C) start with 2 medication classes. Step 3. If blood pressure control is not achieved, for strategy A increase dose of the first drug. For strategy B, add a second drug of a different class. For strategy C, increase doses of initial medications. Step 4. If blood pressure control is not achieved, for strategy A, add a second drug of a different class and titrate doses of both drugs up to maximums. For strategies B and C, titrate doses of both drugs to maximums. Step 5. If blood pressure control is not achieved, add a third drug class from above. Step 6. If blood pressure control is not achieved, add a drug from one of the other medication classes and/or refer to an expert in hypertension management. See Handout 1 for drug choices. Summary of 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). doi: /jama

18 Therapy Sheet E: Propranolol (β-blocker) - Student 1 When prompted during Episode 2, study this page and then ask your colleagues the following questions: 1. What is the mechanism of action of propranolol? There are several mechanisms of action β-blockers use to decrease blood pressure. They decrease cardiac output secondary to a decrease in heart rate, inhibit the release of renin, and to a modest extent suppress CNS preganglionic nerve impulses. Those β-blockers with intrinsic sympathomimetic action (e.g., pindolol) also may cause a modest decrease in peripheral vascular resistance via partial agonist action at β-receptors. Those with an additional α-blocking activity may do so by blocking peripheral α receptors and carvedilol and nebivolol have an additional direct vasodilating activity. 2. What are the advantages, disadvantages, and complications associated with the use of β-blockers? Advantages: β-blockers may be used in any hypertensive disease category. Also they do not contribute to sodium and water retention. Their most frequent use combines the need for antihypertensive therapy and another indication for a β-blockers (e.g., coronary artery disease). They have few serious side effects in otherwise healthy patients. Disadvantages and complications: Bradycardia is a common side effect. They may exacerbate asthma, due to β 2 -blockade, and peripheral vascular disease, due to unopposed α-receptor stimulation. Sudden withdrawal of these drugs can cause anginal attacks, ventricular arrhythmias, and sudden death. Metabolic effects, such as blockade of the adrenergic response to hypoglycemia (tachycardia, nervousness) may leave diabetics without the usual warning signs of a decrease in blood sugar. Lipid soluble drugs may produce CNS effects; sexual impotence has also been reported. These drugs also decrease high-density lipoproteins and increase triglycerides.

Treatment of Essential Hypertension

Treatment of Essential Hypertension 2016 edition by Mark A. Simmons, PhD Department of Pharmaceutical Sciences School of Pharmacy University of Maryland Eastern Shore Originally developed by Hugh J. Burford, PhD, FCP Department of Pharmacology

More information

Hypertension (JNC-8)

Hypertension (JNC-8) Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint

More information

Antihypertensive drugs SUMMARY Made by: Lama Shatat

Antihypertensive drugs SUMMARY Made by: Lama Shatat Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone

More information

Section 3, Lecture 2

Section 3, Lecture 2 59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect

More information

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine

More information

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting

More information

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys

More information

Management of Hypertension

Management of Hypertension Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal

More information

sympatholytics sympatholytics sympatholytics

sympatholytics sympatholytics sympatholytics sympatholytics sympatholytics sympatholytics CNS-ACTING SYMPATHOPLEGICS Sympathetic brain signals Doesn t affect baroreceptor reflex (no orthostatic hypotension) Methyldopa α-methylne crosses BBB (+) α-adrenoreceptors

More information

8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology

8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology Objectives Hypertension (high blood pressure): Clinical Pearls for the Pharmacy Technician Tanya Schmidt PharmD, RPh Director of Central Operations at Thrifty White Pharmacy North Dakota Board of Pharmacy

More information

What in the World is Functional Medicine?

What in the World is Functional Medicine? What in the World is Functional Medicine? An Introduction to a Systems Based Approach of Chronic Disease Meneah R Haworth, FNP-C Disclosure v I am a student of the Institute for Functional Medicine. They

More information

Antihypertensive Agents

Antihypertensive Agents Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,

More information

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between

More information

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes

More information

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment Approaches to Hypertension Treatment Antihypertensives Inhibit Sympathetic impulses Inhibit contractility Inhibit heart rate Inhibit vasoconstriction Inhibit smooth muscle function Inhibit RAAS Inhibit

More information

Beta 1 Beta blockers A - Propranolol,

Beta 1 Beta blockers A - Propranolol, Pharma Lecture 3 Beta blockers that we are most interested in are the ones that target Beta 1 receptors. Beta blockers A - Propranolol, it s a non-selective competitive antagonist of beta 1 and beta 2

More information

Antihypertensives. Diagnostic category

Antihypertensives. Diagnostic category Measurement of blood pressure At first assessment, take both arms then choose the one with the higher reading. Beware of orthostatic hypotension. Measure BP in sitting position, and repeat after patient

More information

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015 Hypertension Update Beverly J. Mathis, D.O. OOA May 2015 Objectives Learn new recommendations for BP treatment goals Approach to hypertension in the office Use of hypertensive drugs, and how to tailor

More information

Difficult to Treat Hypertension

Difficult to Treat Hypertension Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic

More information

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias 1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias Only need to know drugs discussed in class At the end of this section you should

More information

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC HypertensionTreatment Guidelines Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC Objectives: Review the definition of the different stages of HTN. Review the current guidelines for treatment of HTN. Provided

More information

Antihypertensive drugs: I. Thiazide and other diuretics:

Antihypertensive drugs: I. Thiazide and other diuretics: Clinical assessment of hypertensive patient: You have to take history regarding the presence of other risk factors for CAb like diabetes mellitus, smoking, etc. Take history whether the patient takes medications

More information

Hypertension. Penny Mosley MRPharmS

Hypertension. Penny Mosley MRPharmS Hypertension Penny Mosley MRPharmS Outline of presentation Introduction to hypertension Physiological control of arterial blood pressure What determines our bp? What determines the heart rate? What determines

More information

Hypertension Management - Summary

Hypertension Management - Summary Who should have blood pressure assessed? Hypertension Management - Summary All patients over the age of 40 years, every 1-3 years in order to determine their cardiovascular risk (ie. Framingham Risk Score)

More information

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) Beta-blockers have been widely used in the management of angina, certain tachyarrhythmias and heart failure, as well as in hypertension. Examples

More information

M2 TEACHING UNDERSTANDING PHARMACOLOGY

M2 TEACHING UNDERSTANDING PHARMACOLOGY M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To

More information

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu

More information

Antihypertensive Agents

Antihypertensive Agents Antihypertensive Agents Öner Süzer www.onersuzer.com osuzer@istanbul.edu.tr Last update: 13.11.2009 1 Süzer Farmakoloji 3. Baskı 2005 2 1 Süzer Farmakoloji 3. Baskı 2005 3 Süzer Farmakoloji 3. Baskı 2005

More information

Prof dr Aleksandar Raskovic DIRECT VASODILATORS

Prof dr Aleksandar Raskovic DIRECT VASODILATORS Prof dr Aleksandar Raskovic DIRECT VASODILATORS Direct vasodilators Minoxidil (one of the most powerful peripheral arterial dilators) Opening of KATP channels, efflux of K, lose of Ca and smooth muscle

More information

Heart Failure (HF) Treatment

Heart Failure (HF) Treatment Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and

More information

New classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100

New classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100 Hypertension 1 Definition Hypertension can be defined as a condition where blood pressure is elevated to an extent that clinical benefit is obtained from blood pressure lowering. it is an important risk

More information

By Prof. Khaled El-Rabat

By Prof. Khaled El-Rabat What is The Optimum? By Prof. Khaled El-Rabat Professor of Cardiology - Benha Faculty of Medicine HT. Introduction Despite major worldwide efforts over recent decades directed at diagnosing and treating

More information

Introduction. Factors affecting blood pressure: 1-COP = HR X SV mainly affect SBP. 2-TPR = diameter of arterioles X viscosity of blood affect DBP

Introduction. Factors affecting blood pressure: 1-COP = HR X SV mainly affect SBP. 2-TPR = diameter of arterioles X viscosity of blood affect DBP Introduction Hypertension is a persistent elevation of blood pressure above 140 / 90 mmhg for more than three sitting. (0ptimal level

More information

β adrenergic blockade, a renal perspective Prof S O McLigeyo

β adrenergic blockade, a renal perspective Prof S O McLigeyo β adrenergic blockade, a renal perspective Prof S O McLigeyo Carvedilol Third generation β blocker (both β 1 and β 2 ) Possesses α 1 adrenergic blocking properties. β: α blocking ratio 7:1 to 3:1 Antioxidant

More information

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Cardiac Output (CO) CO=SVxHR (stroke volume x heart rate) Cardiac output: The amount of blood

More information

LESSON ASSIGNMENT. After completing this lesson you will be able to:

LESSON ASSIGNMENT. After completing this lesson you will be able to: LESSON ASSIGNMENT SUBCOURSE MD0806 LESSON 7 Therapeutics III. Antihypertensive Agents. LESSON ASSIGNMENT Paragraphs 7-1--7-12. LESSON OBJECTIVES After completing this lesson you will be able to: 7-1. From

More information

DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI

DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI 3. Vasodilators Drugs which dilate blood vessels ( decrease peripheral vascular resistance) by acting on smooth muscle cells through non-autonomic mechanisms:

More information

Heart Failure Clinician Guide JANUARY 2018

Heart Failure Clinician Guide JANUARY 2018 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.

More information

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid Failure? blood supply insufficient for body needs CHF = congestive heart failure increased blood volume, interstitial fluid Underlying causes/risk factors Ischemic heart disease (CAD) 70% hypertension

More information

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris. Lonet Tablet Description Lonet contains Atenolol, a synthetic β1 selective (cardioselective) adrenoreceptor blocking agent without membrane stabilising or intrinsic sympathomimetic (partial agonist) activity.

More information

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None Dr Narender Goel MD (Internal Medicine and Nephrology) drnarendergoel@gmail.com Financial Disclosure: None, Conflict of Interest: None 12 th December 2013, New York Visit us at: http://kidneyscience.info/

More information

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Hypertension Update Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Introduction 1/3 of US adults have HTN More prevalent in non-hispanic

More information

Managing Hypertension in 2016

Managing Hypertension in 2016 Managing Hypertension in 2016: Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu

More information

Cardiovascular drugs

Cardiovascular drugs chapter 13 Cardiovascular drugs Cardiovascular drugs act on the heart or blood vessels to control the cardiovascular system. They are used to treat a variety of conditions from hypertension to chronic

More information

ANTIHYPERTENSIVE DRUGS

ANTIHYPERTENSIVE DRUGS ANTIHYPERTENSIVE DRUGS Course: Integrated Therapeutics 1 Lecturer: Dr. E. Konorev Date: September 28, 2010 Materials on: Exam #3 Required reading: Katzung, Chapter 11 1 1 in 3 adults HYPERTENSION 64% of

More information

Categories of HTN. Overview of Hypertension. Types of Hypertension

Categories of HTN. Overview of Hypertension. Types of Hypertension Categories of HTN Overview of Hypertension Normal SBP 100 Quick review of the Basics: What is

More information

Antihypertensive Agents

Antihypertensive Agents 1. Blood Pressure Regulation Antihypertensive Agents - 2007 Edward JN Ishac. Ph.D. Associate Professor, Dept. Pharmacology & Toxicology Office: Smith 742; Tel: 828 2127 eishac@hsc.vcu.edu Frank's formula,

More information

Chapter 2 ~ Cardiovascular system

Chapter 2 ~ Cardiovascular system Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection

More information

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati CHAPTER-I CARDIOVASCULAR SYSTEM Hypertension SUB: PHARMACOTHERAPEUTICS-I CODE:T0820006 Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati Hypertension

More information

Heart Failure Clinician Guide JANUARY 2016

Heart Failure Clinician Guide JANUARY 2016 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.

More information

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured. Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.

More information

Combining Antihypertensives in People with Diabetes

Combining Antihypertensives in People with Diabetes Combining ntihypertensives in People with Diabetes The majority of people with diabetes will develop hypertension and this subsequently increases the risk of microvascular and macrovascular complications.

More information

ANTIHYPERTENSIVE AGENTS AND VASODILATORS. Lecture 5

ANTIHYPERTENSIVE AGENTS AND VASODILATORS. Lecture 5 ANTIHYPERTENSIVE AGENTS AND VASODILATORS Lecture 5 Hypertension Blood pressure BP = CO x PVR n Interaction between autonomic nervous system, cardiovascular system and renal system Normal: 110/70 Prehypertension

More information

PRINCIPLES OF DIURETIC ACTIONS:

PRINCIPLES OF DIURETIC ACTIONS: DIURETIC: A drug that increases excretion of solutes Increased urine volume is secondary All clinically useful diuretics act by blocking Na + reabsorption Has the highest EC to IC ratio = always more sodium

More information

Preventing and Treating High Blood Pressure

Preventing and Treating High Blood Pressure Preventing and Treating High Blood Pressure: Finding the Right Balance of Integrative and Pharmacologic Approaches Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Blood Pressure

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,

More information

Top 200 Section 4. Cardiovascular Drugs

Top 200 Section 4. Cardiovascular Drugs Top 200 Section 4 Cardiovascular Drugs Objectives After finishing this presentation the audience should be able to: Describe conditions/disease states that would make a person a candidate for drug therapy.

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%

More information

Modern Management of Hypertension

Modern Management of Hypertension Modern Management of Hypertension Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Hypertension Prevalence

More information

Hypertension Epidemiology 6% of deaths worldwide Defined as any of the following: systolic blood pressure 140 mmhg, diastolic blood pressure 90 mmhg, taking antihypertensive medications Pulse pressure=

More information

Network Hypertension Algorithm

Network Hypertension Algorithm Network Hypertension Algorithm Content Review and Approval: This document is subject to review, revision, and (re)approval by the Clinical Integration and Oversight Committee (CIOC) annually and following

More information

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014 Antihypertensive Drugs Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014 Antihypertensive Drugs What is Hypertension: A common, incurable, persistent, but usually

More information

Modern Management of Hypertension: Where Do We Draw the Line?

Modern Management of Hypertension: Where Do We Draw the Line? Modern Management of Hypertension: Where Do We Draw the Line? Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Blood Pressure

More information

The Failing Heart in Primary Care

The Failing Heart in Primary Care The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and

More information

ANTIHYPERTENSIVES. Assoc. Prof. Bilgen Başgut

ANTIHYPERTENSIVES. Assoc. Prof. Bilgen Başgut ANTIHYPERTENSIVES Assoc. Prof. Bilgen Başgut Hypertension Hypertension is a condition in which the blood pressure is persistently higher than normal Hypertension > 140 mmhg > 90 mmhg Systolic Blood Pressure

More information

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D HEART FAILURE PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Understand the effects of heart failure in the body

More information

Hypertension Management: A Moving Target

Hypertension Management: A Moving Target 9:45 :30am Hypertension Management: A Moving Target SPEAKER Karol Watson, MD, PhD, FACC Presenter Disclosure Information The following relationships exist related to this presentation: Karol E. Watson,

More information

Cardiovascular Pharmacotherapy

Cardiovascular Pharmacotherapy Cardiovascular Pharmacotherapy Overview Mechanism of cardiovascular drugs Indications and clinical use in cardiology Renin-Angiotensin Inhibitors: Angiotensin-Converting Enzyme Inhibitors, Angiotensin

More information

University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D

University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D Cardiovascular Pharmacology 1. Antihypertensives 2. Antianginal 3. Drugs for HF 4. Antiarrythemics 5. Drugs for Hyperlipoproteniemia

More information

Management of High Blood Pressure in Adults

Management of High Blood Pressure in Adults Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) James, P. A. (2014, February 05). 2014 Guideline for Management

More information

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL HYPERTENSION IN CKD LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL Stages in Progression of Chronic Kidney Disease and Therapeutic Strategies Complications Normal Increased risk Damage GFR

More information

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing

More information

HTN of pregnancy is serious and must be controlled, because without monitoring it can develop into pre-eclampsia and finally to eclampsia.

HTN of pregnancy is serious and must be controlled, because without monitoring it can develop into pre-eclampsia and finally to eclampsia. Sheet Pharmacology #7 1 Antihypertensive drugs of pregnancy: ببسسممم الله االرححممننن االرححيممم Usage of normal drugs of chronic HTN is controversial in pregnancy, because after few weeks or second trimester,

More information

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation

More information

ANTI- HYPERTENSIVE AGENTS

ANTI- HYPERTENSIVE AGENTS CLINICAL ANTI- HYPERTENSIVE AGENTS Jacqueline van Schoor, MPharm, BSc (Hons) Amayeza Info Centre Hypertension represents a major public health concern. It affects about a billion people worldwide and is

More information

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP What is normal blood pressure? Prehypertension 130-139/80-90 Compared with normal BP Double the risk for developing hypertension. Lifestyle

More information

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC COMPLEX HYPERTENSION Anita Ralstin, FNP-BC Next Step Health Consultant, LLC Incidence Of Hypertension About 70 million American adults have high blood pressure. About 33% of the population Only 52% have

More information

Pharmacology I [PHL 313] Diuretics. Dr. Mohammad Nazam Ansari

Pharmacology I [PHL 313] Diuretics. Dr. Mohammad Nazam Ansari Pharmacology I [PHL 313] Diuretics Dr. Mohammad Nazam Ansari Renal Pharmacology Kidneys: Each adult kidney weighs 125-170g in males and 115-155g in females, represent 0.5% of total body weight, but receive

More information

Heart Failure. Dr. Alia Shatanawi

Heart Failure. Dr. Alia Shatanawi Heart Failure Dr. Alia Shatanawi Left systolic dysfunction secondary to coronary artery disease is the most common cause, account to 70% of all cases. Heart Failure Heart is unable to pump sufficient blood

More information

Byvalson. (nebivolol, valsartan) New Product Slideshow

Byvalson. (nebivolol, valsartan) New Product Slideshow Byvalson (nebivolol, valsartan) New Product Slideshow Introduction Brand name: Byvalson Generic name: Nebivolol, valsartan Pharmacological class: Beta-blocker + angiotensin II receptor blocker (ARB) Strength

More information

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE School of Medicine, The University of Jordan October, 2017

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE School of Medicine, The University of Jordan October, 2017 Antihypertensive Drugs Munir Gharaibeh, MD, PhD, MHPE School of Medicine, The University of Jordan October, 2017 Antihypertensive Drugs What is Hypertension? A common, incurable, persistent, but usually

More information

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure? Disclosure Heart Failure Guideline Review and Update I have had no financial relationship over the past 12 months with any commercial sponsor with a vested interest in this presentation. Natalie Beiter,

More information

Hypertension: Update

Hypertension: Update Hypertension: Update Meenakshi A Bhalla MD,FACC Associate Professor of Medicine Director Preventive Cardiology Advanced Heart Failure and Transplant Cardiology University of Kentucky Faculty Disclosure

More information

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder

More information

Amlodipine plus Lisinopril Tablets AMLOPRES-L

Amlodipine plus Lisinopril Tablets AMLOPRES-L Amlodipine plus Lisinopril Tablets AMLOPRES-L COMPOSITION AMLOPRES-L Each uncoated tablet contains: Amlodipine besylate equivalent to Amlodipine 5 mg and Lisinopril USP equivalent to Lisinopril (anhydrous)

More information

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg Hypertension diagnosis (see detail document) Non-diabetic Diabetic Very elderly (older than 80 years) Target less than 140/90mmHg Target less than 130/80mmHg Consider SBP target less than 150mmHg Non-diabetic

More information

Hypertension. Most important public health problem in developed countries

Hypertension. Most important public health problem in developed countries Hypertension Strategy for Continued Success in Treatment for the 21st Century November 15, 2005 Arnold B. Meshkov, M.D. Associate Professor of Medicine Temple University School of Medicine Philadelphia,

More information

Antihypertensive Drugs. Nafrialdi

Antihypertensive Drugs. Nafrialdi Antihypertensive Drugs Nafrialdi 1 Mechanisms of Blood Pressure Regulation Blood Presure Cardiac Output Peripheral Resistance Heart Rate Stroke volume Vascular tone Vessel elasticity Myocardial contractility

More information

STANDARD treatment algorithm mmHg

STANDARD treatment algorithm mmHg STANDARD treatment algorithm 130-140mmHg (i) At BASELINE, If AVERAGE SBP 1 > 140mmHg If on no antihypertensive drugs: Start 1 drug: If >55 years old / Afro-Caribbean: Calcium channel blocker (CCB) 2 If

More information

Adult Blood Pressure Clinician Guide June 2018

Adult Blood Pressure Clinician Guide June 2018 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Blood Pressure Clinician Guide June 2018 Adult Blood Pressure Clinician Guide June 2018 Introduction This Clinician Guide is based on the 2018

More information

DROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC

DROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC DROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC Pharmacotherapy of HTN Rationale for reducing arterial pressure Reduce cardiac output Reduce heart rate Reduce stroke

More information

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances

More information

Drugs Used in Heart Failure. Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia

Drugs Used in Heart Failure. Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia Drugs Used in Heart Failure Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia Heart Failure Heart failure (HF), occurs when cardiac output is inadequate to

More information

Medical Management of Acutely Decompensated Heart Failure. William T. Abraham, MD Director, Division of Cardiovascular Medicine

Medical Management of Acutely Decompensated Heart Failure. William T. Abraham, MD Director, Division of Cardiovascular Medicine Medical Management of Acutely Decompensated Heart Failure William T. Abraham, MD Director, Division of Cardiovascular Medicine Orlando, Florida October 7-9, 2011 Goals of Acute Heart Failure Therapy Alleviate

More information

Hypertension Management: Making Sense of Guidelines and Therapy Options for the Elderly

Hypertension Management: Making Sense of Guidelines and Therapy Options for the Elderly Butler University Digital Commons @ Butler University Scholarship and Professional Work COPHS College of Pharmacy & Health Sciences 2015 Hypertension Management: Making Sense of Guidelines and Therapy

More information

Blood pressure (BP) control. Hypertension

Blood pressure (BP) control. Hypertension Blood pressure (BP) control Normal heart function Blood pressure (BP) control blood pressure (BP) cardiac output (CO) = total peripheral resistance (TPR) heart rate (HR) filling pressure arteriolar volume

More information

Table 1. Diuretics. Drugs Mechanisms of Action Indications Adverse Drug Effects. Table 2. Electrolyte Modifiers.

Table 1. Diuretics. Drugs Mechanisms of Action Indications Adverse Drug Effects. Table 2. Electrolyte Modifiers. Table 1. Diuretics. hydrochlorothiazide 23 furosemide 23 triamterene 23 Inhibits sodium reabsorption at the distal convoluted tubule Inhibits sodium reabsorption at the loop of Henle Competitive inhibitor

More information

ASEBP and ARTA TARP Drugs and Reference Price by Categories

ASEBP and ARTA TARP Drugs and Reference Price by Categories ASEBP Pantoprazole Sodium 40 mg (generic) $0.2016 ASEBP Dexlansoprazole 30 mg Dexlansoprazole 60 mg Esomeprazole 10 mg Esomeprazole 20 mg Esomeprazole 40 mg Lansoprazole 15 mg Lansoprazole 30 mg Omeprazole

More information

Factors Involved in Poor Control of Risk Factors

Factors Involved in Poor Control of Risk Factors Factors Involved in Poor Control of Risk Factors Patient compliance Clinical inertia Health Care System structure 14781 M Limitations of Formal Studies Selection of patients Recruitment and follow-up alter

More information